CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −191 | $56.27 | $11K | 134,215 |
| 2026-06-22 | Slaoui Moncef Director | Grant or award · Stock Option (right to buy) | +26,061 | 26,061 | ||
| 2026-06-18 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +225 | $1.79 | $403 | 497,164 |
| 2026-06-18 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −225 | $52.51 | $12K | 496,939 |
| 2026-06-18 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −22,236 | $52.50 | $1.2M | 474,703 |
| 2026-06-18 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,000 | $52.50 | $53K | 135,215 |
| 2026-06-18 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,000 | $52.50 | $53K | 135,215 |
| 2026-06-18 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −225 | 0 | ||
| 2026-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +10,000 | $5.35 | $54K | 114,395 |
| 2026-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −10,000 | $53.00 | $530K | 104,395 |
| 2026-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 236,827 | ||
| 2026-06-15 | Lee Jacks Director | Grant or award | +2,265 | 6,856 | ||
| 2026-06-15 | Lee Jacks Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-15 | Loxam Teri Director | Grant or award | +2,265 | 12,481 | ||
| 2026-06-15 | Loxam Teri Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-15 | Furey John Director | Grant or award | +2,265 | 5,306 | ||
| 2026-06-15 | Furey John Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-15 | Paya Carlos V Director | Grant or award | +2,265 | 6,856 | ||
| 2026-06-15 | Paya Carlos V Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2026-06-15 | Gilbert Halley E Director | Grant or award | +2,265 | 12,481 |
Page 5 of 16 · 319 trades